Physician
General Surgery
Dr. Matthew J. Delano, MD
|
|
Give Review
Matthew Delano works in the field of General Surgery. He graduated from Temple University School of Medicine. He received awards:"Fellow (FACS)". Matthew Delano is also published. He has 28 publications published. The lastest publication: "Pre-Hospital Resuscitation of Traumatic Hemorrhagic Shock with Hypertonic Solutions Worsen Hypo-Coagulation and Hyper-Fibrinolysis.' He accepts all Medicare patients.
Publications
- Pre-Hospital Resuscitation of Traumatic Hemorrhagic Shock with Hypertonic Solutions Worsen Hypo-Coagulation and Hyper-Fibrinolysis.
- Novel Role for Tumor-Induced Expansion of Myeloid-Derived Cells in Cancer Cachexia.
- Maintenance of Anti-Sm/RNP Autoantibody Production by Plasma Cells Residing in Ectopic Lymphoid Tissue and Bone Marrow Memory B Cells.
- CXCR3 blockade: a novel anti-sepsis approach?
- Neutrophil Mobilization from the Bone Marrow during Polymicrobial Sepsis Is Dependent on CXCL12 Signaling.
- B cells enhance early innate immune responses during bacterial sepsis.
- Critical role for CXCL10 (IP-10)/CXCR3 signaling in the murine neonatal response to sepsis.
- A paradoxical role for myeloid-derived suppressor cells in sepsis and trauma.
- Sepsis induces early alterations in innate immunity that impact mortality to secondary infection.
- Incidence, clinical predictors, genomics, and outcome of acute kidney injury among trauma patients.
- Cutting edge: bacterial infection induces hematopoietic stem and progenitor cell expansion in the absence of TLR signaling.
- Type I interferon signaling in hematopoietic cells is required for survival in mouse polymicrobial sepsis by regulating CXCL10.
- Traditional resuscitative practices fail to resolve metabolic acidosis in morbidly obese patients after severe blunt trauma.
- Differences in outcome between obese and nonobese patients following severe blunt trauma are not consistent with an early inflammatory genomic response.
- Magic bullets and surrogate biomarkers circa 2009.
- Cancer-induced expansion and activation of CD11b+ Gr-1+ cells predispose mice to adenoviral-triggered anaphylactoid-type reactions.
- Myeloid-derived suppressor cells in cancer cachexia syndrome: a new explanation for an old problem.
- Defective innate immunity predisposes murine neonates to poor sepsis outcome but is reversed by TLR agonists.
- Increased mortality and altered immunity in neonatal sepsis produced by generalized peritonitis.
- Treatment with GITR agonistic antibody corrects adaptive immune dysfunction in sepsis.
- MyD88-dependent expansion of an immature GR-1(+)CD11b(+) population induces T cell suppression and Th2 polarization in sepsis.
- Increased natural CD4+CD25+ regulatory T cells and their suppressor activity do not contribute to mortality in murine polymicrobial sepsis.
- The origins of cachexia in acute and chronic inflammatory diseases.
- Superoxide production by macrophages and T cells is critical for the induction of autoreactivity and type 1 diabetes.
- Braun enteroenterostomy is associated with reduced delayed gastric emptying and early resumption of oral feeding following pancreaticoduodenectomy.
- Emerging implications of nanotechnology on cancer diagnostics and therapeutics.
- Laparoscopic esophagomyotomy for achalasia: does anterior hemifundoplication affect clinical outcome?
Schools
Temple University
Doctors Specialties
- Critical Care Surgery
- General Surgery
Accepted Insurances
- Choice Plus POS II
- Blue Card PPO
- Blue Cross Blue Shield of Illinois PPO
- Blue Care Network PCP Focus Network
- Group Employees PPO
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- First Health (Coventry Health Care) PPO
- Preferred PPO
- Choice Care PPO
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- Priority PPO
- Options PPO
- United Healthcare
Awards
- Fellow (FACS)
Education
-
University of Washington -
University of Florida -
Temple University School of Medicine
Hospital
-
University of Michigan Hospitals and Health Centers
Drug Facts
| NPI NUMBER | 1962537316 | |
| NPPES Provider LastName | DELANO | |
| NPPES Provider FirstName | MATTHEW | |
| NPPES Provider ZIPCode | 481095332 | |
| NPPES Provider State | MI | |
| Specialty Description | General Surgery | |
| Total Claim Count | 52.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 31.0 | |
| Percent Opioid Claims | 59.62 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1962537316 |
| Last Name Of The Provider | DELANO |
| First Name Of The Provider | MATTHEW |
| View All |
Similar Doctors
|
|
Dr. Robert C. Matthias Jr., MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David W. Mozingo, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Larry K. Chidgey, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Chasen A. Croft, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Timothy C. Flynn, MD |
|
|
Dr. Alicia M. Mohr, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kevin E. Behrns, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Maurice D. Levy, MD |
|
|
Dr. Aimal Khan, MD |
|
|
Dr. Joseph W. Melendez-Davidson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Walter W. Scott Jr., MD |
|
|
Dr. Fitzgerald J. Casimir, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Scott C. Brakenridge, MD
This Doctor is OpenDoctor Recommended.
|